This is underpinned by the presence of immunoreactive IFN-α in beta cells of diabetic patients and the few patients with APS-1 without IFN-α autoantibodies, which are more prone to type 1 diabetes and thyroid disease.42 Here, IFNA1 is linked to autoimmune polyendocrine syndrome type 1.